Riyadh - Sharikat Mubasher: Insulet Corporation, a global leader in tubeless insulin pump technology and maker of the Omnipod® Insulin Management System, opened its Middle East and North Africa (MENA) headquarters in Riyadh, marking a strategic milestone in Saudi Arabia.
The new RHQ will house Insulet's full regional leadership and operational functions, serving as the primary hub for clinical engagement, partner development, market access, and talent investment across the Middle East, the company revealed in a press release today.
The launching ceremony was held on 8 May and featured leading clinicians and healthcare professionals for expert‑led discussions on the early experience with Omnipod® 5.
Bernard Brisolier, General Manager for Middle East, Africa, and Turkey at Insulet Corporation, said: “Opening our regional headquarters in Riyadh is one of the most significant commitments Insulet has made in this part of the world. The establishment of a regional base enables Insulet to move beyond a transactional presence and into a genuine, ongoing partnership with Saudi Arabia’s clinical and institutional ecosystem.”
He highlighted that the Riyadh HQ will pave the way for joint work on care pathways, clinical education, patient access programs, and the integration of digital health solutions into existing healthcare infrastructure.
The launching ceremony showcased the early experience with Omnipod® 5, the first tubeless hybrid closed‑loop system, and how real‑world clinical evidence is being translated into everyday practice in Saudi Arabia.
